Integrity Applications, Inc. Share Price Other OTC
Equities
IGAP
US45824Q1013
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 5.46M 456M |
---|---|---|---|---|---|
Net income 2022 | -4M -334M | Net income 2023 | -7M -584M | EV / Sales 2022 | - |
Net cash position 2022 | 2.12M 177M | Net cash position 2023 | 4.3M 358M | EV / Sales 2023 | - |
P/E ratio 2022 |
-4.92
x | P/E ratio 2023 |
-0.68
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 64.57% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Goode
CEO | Chief Executive Officer | 56 | 17/20/17 |
James Cardwell
DFI | Director of Finance/CFO | 64 | 11/23/11 |
David Hammond
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Drew Sycoff
BRD | Director/Board Member | 57 | 08/19/08 |
Luis J. Malavé
CHM | Chairman | 61 | 13/02 |
Director/Board Member | 95 | 01/10/01 |
1st Jan change | Capi. | |
---|---|---|
+2.62% | 42.75B | |
+47.70% | 41.61B | |
+12.01% | 41.34B | |
-8.83% | 26.59B | |
+7.72% | 25.49B | |
-22.68% | 18.12B | |
+30.90% | 12.24B | |
-1.75% | 11.76B | |
+9.55% | 11B |